MiniMed Group, a global provider of integrated insulin delivery technologies, has secured CE (Conformité Européenne) Mark approval to use the MiniMed 780G system with the Instinct sensor developed by Abbott. The authorisation broadens the number of compatible sensors available for the company’s automated insulin delivery platform, expanding options for users of the system.
“At MiniMed, every advancement begins with listening to the needs of people living with diabetes,” said Que Dallara, CEO of MiniMed. “By offering more sensor flexibility within a fully integrated system backed by the proven clinical outcomes of our MiniMed™ 780G system1,2,3,4 we’re helping lighten the burden of daily management and giving individuals the freedom to choose what works best for them.”
The MiniMed 780G system already supports the Guardian™ 4 and Simplera Sync™ sensors, each designed to provide up to seven days of wear time. Following the latest approval, the system will also operate with the Instinct sensor, which has been developed exclusively by Abbott for MiniMed’s automated insulin delivery (AID) system. The Instinct sensor is described as the world’s smallest, thinnest and most discreet continuous glucose monitoring (CGM) sensor and can be worn for up to 15 days.
With the addition of the Instinct sensor, individuals using the MiniMed™ 780G system can now select between sensors offering either 7-day or 15-day wear durations, enabling greater flexibility depending on personal preference and lifestyle requirements. MiniMed plans to introduce the MiniMed™ 780G system with the Instinct sensor commercially in the first European countries during the summer of 2026. The company also intends to showcase the complete system at the 19th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2026) scheduled to take place in Barcelona from March 11–14, 2026. In Europe, the MiniMed™ 780G system is indicated for individuals aged two years and older with insulin-requiring diabetes (type 1 and type 2) whose total daily insulin dose is six units or more, and the system is also CE marked for use during pregnancy.
